They just IPOed in Jan and raised 30ish million then. So they are good for this phase 1 and should have the phase 2 covered.
They are hoping for drug approval after the phase 2. So touch and go wether a CR will be required. A broker report earlier this year suggested a CR would be required, but they were looking at a phase 3 trial being required. Which wont be required hopefully.
Last 4C shows money in the bank end of last quarter. Next 4C due end of month.
Very low SOI.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $50.77K | 12.69M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2602327 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 18629873 | 23 |
View Market Depth
| Last trade - 15.15pm 25/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |